Pharmaco - Press Releases

Date	Title	Company
16-Nov-2020	Allergan Aesthetics Celebrates Second Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day	AbbVie
16-Nov-2020	Cygnal Therapeutics Named to Chemical & Engineering News' 10 Start-Ups to Watch List	Cygnal Therapeutics
16-Nov-2020	Happiness Biotech Starts Offering Kingdomway Coenzyme Q10 in Its Experience Stores	Happiness Biotech Group Limited
16-Nov-2020	Q BioMed's Uttroside-B Receives U.S. Patent in Treatment of Liver Cancer	Q BioMed Inc.
16-Nov-2020	PTC Therapeutics Highlights Data on High Disease Burden and Value of Treatment Across Two Rare Diseases	PTC Therapeutics, Inc.
16-Nov-2020	Astellas to Present New Data on Gilteritinib in FLT3 Mutation-Positive Acute Myeloid Leukemia at the 2020 American Society of Hematology Annual Meeting	Astellas Pharma Inc.
16-Nov-2020	Calypso Biotech Announces Successful Dosing of First Phase 1 Cohort with Anti-Interleukin-15 (IL-15) Monoclonal Antibody CALY-002 for the Treatment of Autoimmune Diseases	B3C newswire
16-Nov-2020	Lead Pharma Enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases	B3C newswire
16-Nov-2020	Watson-Marlow Limited Ireland announces plans for new facility in Cork	Sciad Newswire
16-Nov-2020	Dermapharm Holding SE continues on its growth course in third quarter of 2020	Dermapharm Holding SE
16-Nov-2020	Lupin Announces FDA Filing Acceptance of Supplemental New Drug Application for Solosec® (secnidazole) for the Treatment of Trichomoniasis	Lupin Pharmaceuticals, Inc.
16-Nov-2020	Innovent Announces the Results of the Phase I Clinical Trial of IBI302, a First-in-class Ophthalmic Recombinant Human Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2020 American Academy of Ophthalmology	Innovent Biologics, Inc.
16-Nov-2020	Innovent Announces the Results of the Phase I Clinical Trial of IBI302, a First-in-class Ophthalmic Recombinant Human Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2020 American Academy of Ophthalmology	Innovent Biologics, Inc.
15-Nov-2020	Allen Carr's Easyway Assigns World-leading Quit Smoking Star To Help American Smokers & Vapers	Allen Carr's Easyway
14-Nov-2020	Biortus Announces Round A Financing and Launches Global Cryo-EM Innovation Center	Wuxi Biortus Biosciences Co. Ltd.
13-Nov-2020	China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results	China Pharma Holdings, Inc.
13-Nov-2020	Amgen To Present At The Jefferies Virtual London Healthcare Conference	Amgen
13-Nov-2020	CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)	Menarini I.F.R.
13-Nov-2020	EISAI ANNOUNCES EUROPEAN COMMISSION APPROVAL FOR FYCOMPA® (PERAMPANEL) USE IN CHILDREN WITH EPILEPSY	EISAI
13-Nov-2020	Leading Generic Drug Makers Unite to Pledge Capacity for Developing and Delivering Affordable COVID-19 Interventions as Pandemic Intensifies	The Medicines Patent Pool (MPP)